RankingsPricing
  1. JP-listed companies
  2. Cytori Cell Research Institute,Inc.

Cytori Cell Research Institute,Inc.JP:3750

Market cap
¥7.5B
P/E ratio
129.9x
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2013		Mar 31,
2014		Mar 31,
2015		Mar 31,
2016		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Profit (loss) before income taxes13029520876-462452594319-654-65-1,166-1,011
Depreciation11163531491050150262275286208
Impairment losses1---25-----205336
Amortization of goodwill5714144---2446464646
Interest expenses26817-------129154
Gain on sale of non-current assets------------688
Gain on forgiveness of debts----------108-48
Decrease (increase) in inventories73-91-52677232215-3,4202473042128915
Decrease (increase) in operational investment securities----------227338-
Increase/decrease in consumption taxes payable/consumption taxes refund receivable----------35192
Other, net305-347-71-61,532-25-47308-164-31288-91
Subtotal-667-729115-3731,763277-2,7095915-9085-887
Interest paid-25-8-17-8-3-18-40-58-85-90-121-158
Income taxes refund (paid)----251-6-1-2-3-8-3-108
Net cash provided by (used in) operating activities-697-77057-4051,761254-2,751532-83-188-40-1,152
Payments into time deposits-1-1-1-26------150-300-150
Proceeds from withdrawal of time deposits--2-4------600
Purchase of property, plant and equipment-23-30-63-9----12-16-180-159-16
Proceeds from sale of property, plant and equipment-05-0------8,290
Purchase of investment securities-------200-169--56-23-
Purchase of shares of subsidiaries resulting in change in scope of consolidation--------1,604--212--1
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation---380--1,526---1981
Other, net5-17--46426-8799-0-34
Net cash provided by (used in) investing activities644-521973426-1,1901,376-7,4247-216-2838,690
Proceeds from short-term borrowings--612330267-880---500220
Repayments of short-term borrowings---330-394-485--2,800-280----650
Proceeds from long-term borrowings------4,0006,0003002502,540-
Repayments of long-term borrowings-130-----316-21-260-521-539-2,801-5,605
Income from acceptance of investments in silent partnerships-------1,000-8255-
Payments for investments in silent partnerships------------1,137
Other, net-----1514-555-6-6-0-0
Net cash provided by (used in) financing activities122953464-249-278-3931,9376,35815136294-7,173
Net increase (decrease) in cash and cash equivalents65130718-3131,489-1,329562-53470-368-28365
Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation-----------0-